Article
A role for XRCC2 gene polymorphisms in breast cancer risk and survival.
Journal of medical genetics - 1 Jul 2011
Lin Wei-Yu, Camp Nicola J, Cannon-Albright Lisa A, Allen-Brady Kristina, Balasubramanian Sabapathy, Reed Malcolm W R, Hopper John L, Apicella Carmel, Giles Graham G, Southey Melissa C, Milne Roger L, Arias-Pérez Jose I, Menéndez-Rodríguez Primitiva, Benítez Javier, Grundmann Magdalena, Dubrowinskaja Natalia, Park-Simon Tjoung-Won, Dörk Thilo, Garcia-Closas Montserrat, Figueroa Jonine, Sherman Mark, Lissowska Jolanta, Easton Douglas F, Dunning Alison M, Rajaraman Preetha, Sigurdson Alice J, Doody Michele M, Linet Martha S, Pharoah Paul D, Schmidt Marjanka K, Cox Angela
Abstract excerpt
BACKGROUND: The XRCC2 gene is a key mediator in the homologous recombination repair of DNA double strand breaks. It is hypothesised that inherited variants in the XRCC2 gene might also affect susceptibility to, and survival from, breast cancer. METHODS: The study genotyped 12 XRCC2 tagging single nucleotide polymorphisms (SNPs) in 1131 breast cancer cases and 1148 controls from the Sheffield Breast Cancer Study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
